06Feb 2025
Triple Therapy Eases Persistent Cough in Asthma

Triple Therapy Eases Persistent Cough in Asthma

A clinical trial found that FF/UMEC/VI significantly reduced persistent cough in asthma patients over six weeks (p = 0.006). It improved ACQ-5 scores, lung function, and peak expiratory flow without notable adverse effects. The randomized, double-blind study enrolled patients from June 2022 to December 2023, comparing FF/UMEC/VI to placebo. Results showed a rapid and significant therapeutic effect, supporting its use in managing asthma-related cough.

  • #pulmonology

Like

Save

Share